Treatment

Displaying 1 - 10 of 512

Back pain app outperforms physiotherapy in clinical trial

Back pain app outperforms physiotherapy in clinical trial
Kaia Health has announced results from the first randomised controlled trial of its app-based therapy programme for patients with non-specific low back pain. Detailed results of the study were published in the journal, NPJ Digital Medicine and showed that patients using Kaia, a downloadable app for back pain, reported significantly lower pain levels compared to the control group treated with physiotherapy and online education.
13th May 2019

New HIV vaccine using lipid nanoparticle delivery technology

New HIV vaccine using lipid nanoparticle delivery technology
Leti, a research institute of CEA Tech, in collaboration with CEA’s Fundamental Research Divisionand INSERM, has developed a new vaccine approach for HIV based on engineered lipid nanoparticles that deliver p24 - a viral protein that is key to an HIV vaccine - and optimise the CpG adjuvant’s effect.
14th March 2019

Ten million raised to transform chronic pain treatment

Ten million raised to transform chronic pain treatment
The digital therapeutics pioneer, Kaia Health, announced it has raised $10m in a Series A round led by Balderton Capital to tackle some of the world’s most urgent health challenges, including a range of chronic conditions. The investment will be used to support Kaia Health’s US rollout, including a new office in New York City, and fund further clinical studies.
23rd January 2019


Innovative digital healthcare partnership to reduce back pain

Innovative digital healthcare partnership to reduce back pain
Sweden's digital healthcare provider, Min Doktor, which provides doctor-patient communications through voice, video, and text, and allows doctors to issue prescriptions, is pioneering an innovative digital approach to back pain treatment with Kaia Health, a leading digital therapeutics company whose AI app has been shown to reduce back pain by 40%. 
21st December 2018

Cable and connector technology for spinal pain relief

Cable and connector technology for spinal pain relief
  Living with chronic neuropathic pain as a result of an accident or ageing that includes nerve damage can become a constant battle in our daily lives. Modern solutions include the installation of electrical signal pain modulations that help mask some of the pain signals. 
12th November 2018

First minimal-contact full face CPAP mask: AirFit F30

First minimal-contact full face CPAP mask: AirFit F30
ResMed has introduced its first minimal-contact full face CPAP mask, AirFit F30, the latest addition to its AirFit mask portfolio, which helps users reduce facial marks, wear glasses in bed and curl up closer to their bed partner. Unlike most traditional full face mask cushions, AirFit F30’s sits below the nasal bridge, preventing top-of-the-nose red marks and irritation, and reducing feelings of claustrophobia for some full face wearers.
14th September 2018

Veta smart case & app for epinephrine auto-injectors

Veta smart case & app for epinephrine auto-injectors
Aterica has announced the general availability of Vetaf Smart Case & App – the first-ever comprehensive anaphylaxis and food allergy support system for individuals and their families. Veta provides increased security, freedom, and confidence for everyone involved by surrounding individuals living with anaphylaxis with their network of connected Veta Smart Case-enabled epinephrine auto-injectors and with their support circle of family, friends, and caregivers connected through Veta App.
12th September 2018

Device to corral viable sperm may speed IVF process

Device to corral viable sperm may speed IVF process
For couples hoping for a baby via in vitro fertilisation, chances have improved. A process that once took hours now takes minutes: Cornell scientists have created a microfluidic device that quickly corrals strong and speedy sperm viable for fertilisation. Conventional methods to separate vigorous, motile sperm is tedious and may take up to several hours to perform.
12th September 2018

Aortic valve system demonstrates high performance

Aortic valve system demonstrates high performance
A new study evaluating the safety and performance of the Boston Scientific ACURATE neo2 Aortic Valve System, a next generation transcatheter aortic valve implantation (TAVI) system, demonstrated a high procedural success rate and a low rate of paravalvular aortic regurgitation at 30 days post procedure. Results from the ACURATE neo2 CE-Mark Study, a single-arm, multi-center study, were presented at the annual congress of PCR London Valves, in London.
12th September 2018

Special antibodies could lead to HIV vaccine

Special antibodies could lead to HIV vaccine
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the University of Zurich and the University Hospital Zurich have now shown that the genome of the HI virus is a decisive factor in determining which antibodies are formed.
11th September 2018


Treatment documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Sensor+Test 2019
25th June 2019
Germany Nürnberg Messe
DSEI 2019
10th September 2019
United Kingdom EXCEL, London
European Microwave Week 2019
29th September 2019
France Porte De Versailles Paris
Engineering Design Show 2019
16th October 2019
United Kingdom Ricoh Arena, Coventry
ELIV 2019
16th October 2019
Germany Bonn World Conference Center